Tag Archives: OAK

Top Value Stocks To Watch For 2018

A good way to find new stock ideas is to scroll through the Zacks Industry Rank page. From this page you can see the breakdown of 252 different industries and then drill down to the stocks in each industry.

This can help you locate industries that are trading more along the lines of value stocks (those with low forward PE and low book values) and those that have higher earnings growth rates.

One page in particular, the heat map, shows which industries have been moving up the rank over the last few weeks. That led me to the Building Products – Concrete and Aggregates group.

Moving Up The Charts

On April 15, the building products – concrete and aggregates – was #182, but over the next few weeks, the rank improved to #166, #105, #87 and last week made it to #15 where it remains for another week.

So what are the best stocks from this strong group and will they remain this strong?

There are three stocks with a Zacks Rank #1 (Strong Buy) and two stocks that have a Zacks Rank #2 (Buy). You can view the list here (here).

Top Value Stocks To Watch For 2018: Ashford Hospitality Trust Inc(AHT)

Advisors’ Opinion:

  • [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)

     

Top Value Stocks To Watch For 2018: First Harvest Corp., Prior to Reverse Merger with Cannavoices, Inc. (HVST)

Advisors’ Opinion:

  • [By Javier Hasse]

    First Harvest Corp (OTC: HVST), acquired Cannavoices, Inc., a developer of cannabis-focused mobile games and social media platforms.

    "A trend we've seen developing slowly but steadily [is one] wherenew channels are being developed to reach cannabis consumers, primarily due to limits in advertising. There is so much regulation in the space that, in such an entrepreneurial environment where there are really no incumbent leaders, people are trying to be creative and figuring out ways to reach the cannabis consumer, both as an undeserved demographic and, just one that has still got that taboo around it, [leading] to larger players not necessarily getting involved yet." "Basically, they are trying to figure out ways to reach the consumer without direct TV advertising and stuff like that.”

    Related Link: Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High

Top Value Stocks To Watch For 2018: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By WWW.MONEYSHOW.COM]

    Oaktree Capital Group (OAK) is known for its contrarian approach with many of its products concentrating on distressed assets and turnaround situations.

Top Value Stocks To Watch For 2018: Rogers Corporation(ROG)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Wintergreen Fund’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Wintergreen+Fund

    These are the top 5 holdings of Wintergreen FundReynolds American Inc (RAI) – 1,643,159 shares, 24.5% of the total portfolio. Consolidated-Tomoka Land Co (CTO) – 1,232,334 shares, 15.61% of the total portfolio. British American Tobacco PLC (BATS) – 782,405 shares, 12.29% of the total portfolio. Cie Financiere Richemont SA (CFR) – 286,053 shares, 5.35% of the total portfolio. Shares reduced by 15.57%Altria Group Inc (MO) – 305,421

  • [By Anders Bylund]

    Shares of Rogers Corp. (NYSE:ROG) gained 19.9% in April 2017, according to data from S&P Global Market Intelligence.

    So what

    The company reported first-quarter results on April 26, sending share prices nearly 12% higher the next day. Rogers saw 27% year-over-year sales growth and 79% higher earnings, leaving analyst estimates far behind in both cases.

Top Value Stocks To Watch For 2018: CIENA Corporation(CIEN)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, with the Dow Jones Industrials falling while the Nasdaq Composite posted modest gains. Parts of the market reacted differently to conflicting news items, which included both poor performance in the energy market and signs of promise for the economy more broadly. Despite the conflict among industry sectors, some stocks got hit particularly hard, and Rite Aid (NYSE:RAD), Ciena (NYSE:CIEN), and Express (NYSE:EXPR) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Billy Duberstein]

    The reasons for the price drop could be a number of things, including increased competition, notably from Ciena(NYSE: CIEN). This was noted by CEO Thomas Fallon who, in the recent conference call, noted competitors may be trying to “buy” market share:

  • [By Lee Jackson]

    Ciena Corp. (NYSE: CIEN) is another tech company that saw insider selling last week. The president and CEO of the optical giant, Gary Smith, sold a reported 114,318 shares at $24.67 per share. The total for the trade was set at a solid $2,820,225. Shares closed last Friday at $24.41, in a 52-week range of $15.62 to $25.19. The consensus price target is $28.36.

  • [By Trey Thoelcke]

    Ciena Corp. (NYSE: CIEN) will report its most recent quarterly results Thursday morning. The consensus estimates call for EPS of $0.49 and $726.84 million in revenue. Shares closed at $23.87 on Friday, in a 52-week range of $18.94 to $27.98. The consensus price target is $30.77.

  • [By WWW.THESTREET.COM]

    Earnings of note in the coming week include Analogic (ALOG) and Ascena Retail (ASNA) on Monday; Bojangles (BOJA) , H&R Block (HRB) , and Dick’s Sporting Goods (DKS) , Michaels (MIK) , and Urban Outfitters (URBN) on Tuesday; Ciena (CIEN) , Bankrate (RATE) , Express (EXPR) , Vera Bradley (VRA) , and Bob Evans Farms (BOBE) on Wednesday; El Pollo Loco (LOCO) , Hugo Boss (BOSSY) , Party City (PRTY) , Signet Jewelers (SIG) , and Verifone Systems (PAY) on Thursday; and Kirkland’s (KIRK) , and Vail Resorts (MTN) on Friday.

Top Value Stocks To Watch For 2018: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Paul Ausick]

    FitBit Inc. (NYSE: FIT) dropped about 2.2% on Wednesday to post a new 52-week low of $7.48 after closing at $7.65 on Tuesday. The stock’s 52-week high is $30.96. Volume was nearly 30% below the daily average of around 10 million shares. The company had no specific news.

  • [By Peter Graham]

    The Q4 2016 earnings report forsmall cap fitnessdevice stockFitbit Inc (NYSE: FIT) is scheduled for after the market closes onWednesday (February 22nd). Competition in the fitness device and wearables market has made Fitbit Inc theseventh most shorted stock on the NYSE with elevated short interest of 38.92% according to Highshortinterest.com. At the end of January, Fitbit Incs CEOwarned that:

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) lost about 2.4% Tuesday to post a new 52-week low of $8.20 after closing Monday at $8.40. The 52-week high is $34.68. Volume of around 7.1 million was about 30% below the daily average of around 1 million shares traded. The company had no specific news Tuesday.

  • [By Chris Lange]

    Fitbit, Inc. (NYSE: FIT) reported fourth-quarter financial results after the markets closed on Wednesday. So far year to date the stock is down about 20%, and down even further when looking at the past 52-weeks.Theres no doubt that this stock has taken a beating in this time, but are traders finally coming around and calling a bottom to this stock?

  • [By Ashley Moore]

    We saw it with GoPro Inc. (Nasdaq: GPRO) and Fitbit Inc. (NYSE: FIT). Both are trading about 90% below their post-IPO peak prices.

    “The thought that any sane investor would buy Snapchat is frightening,” said Money Morning Capital Wave Strategist Shah Gilani. “Buying shares in SNAP is like trying to pick up nickels in front of buses.”

Best Small Cap Stocks To Buy For 2018

On Tuesday, our Under the Radar Moversnewsletter suggested going long on small cap bioprocessing stock Repligen Corporation (NASDAQ: RGEN):

As for Repligen, this one’s a bit more speculative than usual; we’re betting the long-term shape of the chart takes hold, and benefits us in the short run.

You have to take a big step back to see it, but it’s there – there’s a converging wedge taking shape, and the bulls are winning the war so far. There’s a horizontal ceiling at $33.84 that needs to be cleared, but with a string of higher lows in tow, this third effort on that resistance could be the one to punch through. There’s also a cup-and-handle-ish thing going on here.

Our Under the Radar Moversnewsletter has a further discussion about Repligen Corporations technical chart and a potential long strategy:

Best Small Cap Stocks To Buy For 2018: Care.com, Inc.(CRCM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Care.com Inc (NYSE: CRCM) got a boost, shooting up 16 percent to $11.01 after the company reported upbeat quarterly results.

    MaxPoint Interactive Inc (NASDAQ: MXPT) shares were also up, gaining 19 percent to $5.44. MaxPoint Interactive reported Q4 earnings of $0.59 per share on revenue of $46.3 million.

Best Small Cap Stocks To Buy For 2018: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Oaktree Capital Group (OAK) is known for its contrarian approach with many of its products concentrating on distressed assets and turnaround situations.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

Best Small Cap Stocks To Buy For 2018: MercadoLibre Inc.(MELI)

Advisors’ Opinion:

  • [By Danny Vena]

    Latin American e-commerce leader MercadoLibre, Inc. (NASDAQ:MELI) is scheduled to report the results of its recently completed fourth quarter and full year on Feb. 23. MercadoLibre — which is Spanish for “free market” — saw its share price increase an impressive 42% in 2016. Investors will have a keen eye on the latest results. Here’s a preview of MercadoLibre’s earnings report and a few things to watch on Feb. 23.

  • [By Danny Vena]

    As I have pointed out before, Latin American e-commerce leader Mercadolibre (NASDAQ:MELI)is enjoying some pretty serious demographic and technological tailwinds. With internet, smartphone, and e-commerce penetration far behind comparable adoption in the U.S., these trends will likely continue to drive growth for the foreseeable future. But seeing is believing, right?

  • [By Rick Munarriz]

    Shares of MercadoLibre (NASDAQ:MELI) hit an another all-time high last week, and there’s another Wall Street pro who thinks the dot-com darling is going even higher.Barclays analyst Deepak Mathivanan initiated coverage of MercadoLibre with an overweight rating after Tuesday’s market close. He’s setting a $250 price target on the stock, translating into 18% of upside from yesterday’s close.

  • [By Brian Feroldi, Dan Caplinger, Rich Duprey, Jason Hall, and Jordan Wathen]

    So what other companies could potentially grow at a breakneck speed over the next few decades? We asked a team of Fools that very question, and they pickedMercadoLibre (NASDAQ:MELI),WisdomTree Investments(NASDAQ:WETF),Illumina (NASDAQ:ILMN), First Solar (NASDAQ:FSLR), andNVIDIA (NASDAQ:NVDA). Read on to find out why.

  • [By Javier Hasse]

    “Take Mercadolibre Inc (NASDAQ: MELI), for example. When the stock market fell, they had enough cash in the bank to weather the storm; meanwhile, competitor DeRemate didn’t, and thus ended falling in oblivion. So, the lesson is: money is not a commodity.”

top 10 stock to buy

Why climate change researchers are freaking out When Donald Trump was elected, most people probably weren’t concerned about the future of data. But for some groups, that was top of mind.

Data Refuge was founded after the election, with a goal of tracking and safeguarding government data.

The volunteer group of hackers, writers, scientists and students collects federal data about climate change in order to preserve the information and keep it publicly accessible.

“When things like science are politicized, scientific information will be less accessible,” said Dr. Bethany Wiggin, co-director of Data Refuge. “If you can keep knowledge out of the hands of your political opponents, that’s an effective win.”

top 10 stock to buy: Mosaic Company (The)(MOS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was The Mosaic Co. (NYSE: MOS) which traded down 2.4% at $23.09. The stocks 52-week range is $22.43 to $34.36. Volume was 4.2 million versus the daily average of 5.1 million shares.

  • [By Ben Levisohn]

    Mosaic (MOS) tumbled to the bottom of the S&P 500 today after announcing that it would buy Vale’s (VALE) fertilizer unit.

    Getty Images

    Mosaicdropped 1.1% to $27.77 today, while the S&P 500 advanced 0.2% to 2,262.53.

    Barron’s Dimitra DeFotis covered the deal over at Emerging Markets Daily:

    Global agricultural chemicals giant Mosaic (MOS) is buying most of the fertilizer chemicals business of Brazilian mining giant Vale (VALE) in a cash-and-stock deal valued at $2.5 billion, but Wall Street doesnt seem to like the deal…

    Vale will maintain an 11% stake with ownership nitrogen and phosphate fertilizing assets in the city of Cubat茫o, Reuters reports. Mosaic adds Canada and Peru mines to its empire as part of the deal, according to the Mosaic acquisition press release…

    Mosaic’s market capitalization fell to $9.7 billion today from $10.4 billion yesterday. It reported net income of $1 billion on sales of $8.9 billion in 2015.

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

top 10 stock to buy: Packaging Corporation of America(PKG)

Advisors’ Opinion:

  • [By Paul Ausick]

    Stocks on the move: Boise Inc. (NYSE: BZ) is up 26% at $12.55 following the companys acquisition by Packaging Corporation of America Inc. (NYSE: PKG) for $12.55 a share ($1.28 billion). Omeros Corp. (NASDAQ: OMER) is up 68.2% at $8.56 following an analyst upgrade. Northern Dynasty Minerals Ltd. (NYSEArca: NAK) is down 33.3% at $1.48 following an announcement from Anglo American plc that it was withdrawing from a massive copper mining project in Alaska.

  • [By Daniela Pylypczak]

    Jefferies announced on Monday that it has upgraded Packaging Corp of America (PKG) from “Hold” to “Buy.”

    The firm also raised PKG’s price target from $49.00 to $70.00. Jefferies analystPhilip Ng also gave the companybull-case scenario target of $88. The upgrade comes after the firm announced earlier today that it has agreed to purchase all outstanding shares of Boise Inc. (BZ)for $1.995 billion. Analyst Ng believes the new acquisition will result in an attractive multiple.

    Packaging Corp of America shares rallied 9.73% during Monday’s session. Year-to-date, the stock is up 39.87%.

  • [By David Sterman]

    That was precisely the rationale behind Packaging Corp. of America's (NYSE: PKG) just-announced $2 billion (in cash and assumed debt) acquisition of rival Boise (NYSE: BZ). The deal will create a $6 billion (in sales) behemoth in the cardboard box industry.

  • [By Christopher Freeburn]

    Shares of Packaging Corp. (PKG) jumped almost 13% in pre-market trading on Monday after the company announced that it will purchase a rival containerboard-maker.

  • [By Ben Levisohn]

    Packaging Corp. of America(PKG) has jumped 6.3% to $57.99 after it said it would buy Boise (BZ) for $1.28 billion. Boise has gained 26% to $12.55.

top 10 stock to buy: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Oaktree Capital Group (OAK) is known for its contrarian approach with many of its products concentrating on distressed assets and turnaround situations.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

top 10 stock to buy: Nobilis Health Corp.(HLTH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Nobilis Health Corp (NYSE: HLTH) is expected to report its quarterly earnings at $0.19 per share on revenue of $91.92 million.

    Avid Technology, Inc. (NASDAQ: AVID) is estimated to post its quarterly earnings at $0.36 per share on revenue of $144.02 million.

stock market today chart

It’s busy season for immigration lawyers. On April 3, people can start submitting H-1B visa petitions for the new fiscal year.

The popular visa, beloved by the tech industry, is a pathway for skilled foreigners to work in the U.S.

It’s in high demand: Last year, the cap of 85,000 H-1B visas was reached less than a week after the application period opened up. During that time, 236,000 petitions were submitted.

When demand exceeds supply, the visas are awarded through a lottery system.

And this year, there are additional stress factors: The political environment is decidedly less welcoming to foreigners and one of the favored processing options has been put on hold.

For an additional $1,225 fee, premium processing guarantees that an H-1B petition is reviewed within 15 days (if it’s selected in the lottery). According to USCIS, premium processing filings accounted for 59% of the total H-1B filings in 2016. But in March, USCIS announced it was temporarily freezing that option on April 3.

stock market today chart: Francesca's Holdings Corporation(FRAN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, cyclical consumer goods & services shares fell 0.03 percent. Meanwhile, top losers in the sector included Francesca's Holdings Corp (NASDAQ: FRAN), down 5 percent, and Hibbett Sports, Inc. (NASDAQ: HIBB) down 5 percent.

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

  • [By Ben Levisohn]

    Francesca’s Holdings (FRAN) has jumped 5.4% to $11.00 after beating earnings forecasts.

    Restoration Hardware (RH) has tumbled 20% to $28.92 after slashing its full-year guidance. Restoration Hardware was also cut to Market Perform from Outperform at Telsey Advisory Group.

stock market today chart: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Matthew Briar]

    Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.

    The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.

    Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.

    More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe

  • [By Jim Robertson]

    Last week, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP)announced a deal with Hempco Food and Fiber (OTCMKTS: HMPPF; TSXV: HEMP) that will take hemp foods to the next level. First of all, hemp is a variety of the Cannabis sativa plant species that is grown for the industrial uses of its derived products as the plant material can be refined into justabout anything,including paper, textiles, clothing, biodegradable plastics, paint, insulation, biofuel, food and animal feed:

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Bryan Murphy]

    At first glance, it looks like it could be trouble for Lexaria Bioscience Corp (OTCMKTS:LXRP). That is, on Wednesday, the nation’s Drug Enforcement Agency brought clarity to a rule that had been up in the air since 2011. That is, in short, the DEA’s position on all cannabis extracts, including CBD oil, is that they are all federally illegal Schedule I substances.

    From a legal and logical standpoint based just on the DEA’s language published in the Federal Register yesterday, that puts Lexaria Bioscience in jeopardy. Lexaria has developed a way to improve the body’s absorption of hemp oil — which is deliberately high in cannabidiol/CBD — which was perfectly legal and legitimate since THC percentage in hemp (0.3%or less) are technically legal. Now the federal government’s drug-enforcement arm says that’s not the case. The newly-clarified law defines the illegal substance as “extracts that have been derived from any plant of the genus Cannabis and which contain cannabinols and cannabidiols.” Hemp, even though it’s not marijuana, is of the Cannabis genus.

    Bad news for LXRP owners? Not quite, for a handful of reasons.

    The decision (which bypassed legislature and overstepped the DEA’s authority, by the way – more on that in a second) is evidence of a long-standing problem the government agency has had in dealing with hemp and cannabis. In simplest terms, the DEA has operated and acted as if it has no real understanding of the difference between hemp and marijuana. They are of the same genus, but not of the same species. Moreover, while the former predominantly contains cannabidiol, the latter is sought out for its high tetrahydrocannabinol (or THC) for the purpose of creating a “high.”

    Problem (for the DEA): The U.S. judicial system has already ruled that the DEA doesn’t have the authority to make such rules.

    Attorney Robert Hoban explained yesterday evening at industry website newcannabisventures.com:

stock market today chart: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Oaktree Capital Group (OAK) is known for its contrarian approach with many of its products concentrating on distressed assets and turnaround situations.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

stock market today chart: Rent-A-Center Inc.(RCII)

Advisors’ Opinion:

  • [By Lisa Levin]

    Rent-A-Center Inc (NASDAQ: RCII) was down, falling around 26 percent to $9.88. Rent-A-Center reported upbeat quarterly earnings, but the company’s sales missed analysts’ estimates.

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basically breaking even with Best Buy Co Inc (NYSE: BBY) all over the place (albeit it took off again last year) while small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both underperformed for over three years now:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc performing better with Best Buy Co Inc (NYSE: BBY) being the big winner whilesmall caps hhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII) haveunderperformed, butare showing signs of improvement:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basicallyabove break even with Best Buy Co Inc (NYSE: BBY)taking off againwhile small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both been sliding in recent years:

stock market today chart: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    Tailored Brands (NYSE:TLRD) and National Beverage (NASDAQ:FIZZ) were two of the biggest individual stock movers on Thursday.

    Winners and losers

    Shares of formal clothing specialist Tailored Brands dove 32% after the companyposted surprisingly weak fiscal fourth-quarter earnings results. Sales fell 3.9% to $793 million, while consensus estimates were targeting a more modest decline to $805 million.

  • [By Dan Caplinger]

    Yet some solid individual stock gains also helped lift investors’ moods, and Sears Holdings (NASDAQ:SHLD), National Beverage (NASDAQ:FIZZ), and JetBlue Airways (NASDAQ:JBLU) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top Biotech Stocks To Watch For 2018

Related KERX Mid-Day Market Update: Conn's Drops Following Weak Q1 Results; Achaogen Shares Surge Mid-Morning Market Update: Markets Open Lower; Joy Global Profit Tops Expectations Keryx up 15% on disclosure of Klarman stake (Seeking Alpha)
Related FOLD Amicus Therapeutics Gets European Commission Approval For Galafold in Patients With Fabry Disease Today's Top 10 Pre-Market Gainers Biotech Daily Digest: The Biotech Rally Continues; Another Small Cap Gets Bought Out; Icahn Targets Allergan (Seeking Alpha)

Toward the end of trading Thursday, the Dow traded up 0.18 percent to 17,821.51 while the NASDAQ climbed 0.21 percent to 4,962.80. The S&P also rose, gaining 0.16 percent to 2,102.65.

Leading and Lagging Sectors

Thursday afternoon, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Amicus Therapeutics, Inc. (NASDAQ: FOLD).

Top Biotech Stocks To Watch For 2018: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By WWW.MONEYSHOW.COM]

    Oaktree Capital Group (OAK) is known for its contrarian approach with many of its products concentrating on distressed assets and turnaround situations.

Top Biotech Stocks To Watch For 2018: Diebold, Incorporated(DBD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top Biotech Stocks To Watch For 2018: BioScrip, Inc.(BIOS)

Advisors’ Opinion:

  • [By Chris Lange]

    BioScrip, Inc. (NASDAQ: BIOS) saw its shares make a solid gain on Tuesday after another analyst issued a positive rating on the stock. Lake Street Capital initiated its coverage with a Buy rating and a $4.50 price target. This is implying an upside of over 300% from the previous closing price of $1.04.

  • [By Chris Lange]

    On Tuesday, BioScrip Inc. (NASDAQ: BIOS) reported third-quarter financial results before the markets opened. The company said that it had a net loss of $0.09 per share and $224.5 million in revenues. The consensus estimates from Thomson Reuters had called for a net loss of $0.05 per share and revenues of $223.26 million. The same period of last year reportedly EPS of had $0.04 and $247.22 million in revenues.